Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Considering buying GEHC stock? Here's what analysts think: GE HealthCare Technologies Inc has a consensus price target of $94.81 based on the ratings of 18 analysts. The high is $110 issued by Argus Research on April 1, 2024. The low is $80 issued by Jefferies on November 30, 2023. The 3 most-recent analyst ratings were ...

GE Healthcare Technologies Inc. (GEHC) has announced the receipt of the CE mark for its Vscan Air SL wireless handheld ultrasound system with Caption AI. The company also received the CE mark for the use of ECG-less cardiac computed tomography (CT) scanning on its Revolution Apex platform. The Vscan Air SL with Caption AI facilitates rapid cardiac assessments at the point of care, enabling even nonexperts to capture high-quality cardiac images. It provides real-time visual guidance and automated calculation ...

GE HealthCare Technologies Inc. (GEHC) recently collaborated with the University of California San Diego School of Medicine. The tie-up aims to investigate advanced magnetic resonance imaging (MRI) protocols and techniques for female-specific diseases and conditions of the pelvis and develop comprehensive educational materials for clinicians. The Center for Translational Imaging and Precision Medicine at the University of California San Diego School of Medicine will be the collaborating site to conduct the ...

Tom Werner/DigitalVision via Getty Images I am updating my previous analysis on GE HealthCare Technologies Inc. (NASDAQ:GEHC) in light of Q2 2024 earnings which were released on July 31st, 2024. I previously rated GE HealthCare a hold for the following reasons: GE HealthCare was lagging market growth across its businesses. The AI business had potential, but I didn't believe management was correctly counting the impact of competition in their expectations. DCF generated price target of $74 was essentially fl ...

GE HealthCare (GEHC) reported second-quarter 2024 adjusted earnings per share (EPS) of $1, which beat the Zacks Consensus Estimate by 2%. Also, the bottom line improved 8.7% year over year. GAAP EPS in the quarter was 93 cents, up 2.2% from the year-ago quarter's level. Revenue Details The company reported revenues of $4.8 billion, up 0.5% on a reported basis from the prior-year quarter and up 1.3% organically. Total company orders increased 3% organically year over year. However, the top line missed the Za ...

2Q 2024 Earnings Presentation July 31, 2024 © 2024 GE HealthCare. GE is a trademark of General Electric Company used under trademark license. Forward-looking statements and additional information This presentation contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as "will," "expect," "may," "would," "could," "plan," "believe," "anticipate," "intend," "estimate," "potential," "position," "forecast," "target," "guidance," "outlook ...

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q2 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President & CEO Jay Saccaro - VP & CFO Conference Call Participants Joanne Wuensch - Citi Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Group Vijay Kumar - Evercore ISI David Roman - Goldman Sachs Matthew Taylor - Jefferies Graham Doyle - UBS Patrick Wood - Morgan Stanley Suraj Kalia - Oppenheimer Operator G ...

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.92 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 2.04%. A quarter ago, it was expected that this medical technology company would post earnings of $0.90 per share when it actually produced earnings of $0.90, delivering no surprise. Over the last four qua ...

Analyst Estimates for Q2 2024 Q1 2024 Q2 2023 Revenue $4.9 billion $4.65 billion $4.82 billion Diluted EPS 91 cents 81 cents 91 cents Net Income $418.52 million $374 million $418 million GE HealthCare shares have lost about 9.5% of their value since the company's first-quarter earnings miss, though they've gained 4% since the start of 2024 at $80.50 as of Friday's close. Key Metric: Revenue However, the company affirmed its full-year guidance despite lackluster first-quarter results, as CEO Peter Arduini sa ...

Let's take a look at how things might have shaped up for GEHC prior to the announcement. Overall, imaging demand is healthy, especially for Molecular Imaging, Computed Tomography and Magnetic Resonance, supporting top-line growth. Moreover, the company completed the acquisition of MIM Software in April. GEHC added IM SurePlan and MIM Symphony families, MIM Maestro and MIM Encore, among others, to its product portfolio. These products are likely to have brought additional revenues during the soon-to-bereport ...